This network aims to proactively improve the employment satisfaction of EMCRs. We realise that to build innovation in Australia there needs to be a strong connection between academic researchers and clinical and commercial bodies. Our network will foster these interactions.

You can join our network using this link.

The Network was established in October 2013, co-founded by Dr Charlene Lobo and Dr Heather Main as a result of attending the EMCR forum event “Science Pathways 2013: engaging with industry and innovation”. It was clear to us that EMCRs needed opportunities to interact with those outside of academia towards building up the translational sectors in Australia. Dr Iva Nikolic was a critical and welcome addition to driving the success of the network.

The EMCR Network of NSW builds links between academic and commercial sectors to promote individual career opportunities and provide industry with access to world class researchers.

Activities of the network will be focussed on;

1) providing EMCRs with information and opportunities to enhance their career development. These events reflect the breadth of career options and are targeted towards industry demand and the needs of our membership.

2) promoting interaction between academic and industry EMCRs

3) developing skill sets towards translation of research into other fields

4) building professional networks amongst our membership, thereby generating opportunities for them.

5) working with the national EMCR forum and academic EMCR organsations to promote the interests of EMCRs, and the goals stated above.


For all enquiries and membership please contact: emcrnetworknsw@gmail.com

Our Committee

In April of 2015 we registered as an incorporated organisation forming a constitution and official committee. The committee is made of a mix of academic and commercial PhDs all dedicated to building research and innovation in Australia;

Dr Christina Lui – President.
christina bio

Christina is a Research Scientist at the Westmead Millenium Institute in the Gene Expression Lab. Her research focuses on the use of biochemistry and basic molecular biology to understand the mechanisms of oncogenesis in colorectal cancer. Despite only a short time in the medical research arena she has been involved in a range of projects, from neuropathology using animal models, to the specialisation in hi-tech fluorescence microscopy.

Christina believes that effective communication and strong ties between research and private companies is key to driving innovation success. She also recognises the support to facilitate this process is still lacking, particular for early-mid career researchers. She aims to drive and strengthen the connection between academics and the private sectors through the EMCR Network.


Dr Evelyn Linardy – Vice President.


Evelyn is a Scientist at a Sydney biotech startup called SpeeDx. Her research focus is in the development of molecular technology for diagnosis of diseases at the point of care. Her 5 years industry experience and further commercialisation training allowed her to develop a passion for innovation. She has recently taken an additional role as Marketing Coordinator at the company, aiming to learn more about market strategy whilst liaising with healthcare professionals to learn how molecular technology could improve their current practices.

Evelyn realised that there is a need for a wide variety of skills and a network of brilliant people to successfully translate bench-top research to community. Through EMCR Network of NSW, Evelyn hopes to facilitate the meetings of passionate individuals across industries, thus improving the many facets of research and innovation.


Dr Fatima El-Assaad – Secretary.

FEA_Profile Image

Fatima is a Vice Chancellor’s Postdoctoral Research Fellow at the University of New South Wales (UNSW) at St George and Sutherland Clinical School. She is an early career medical scientist currently studying the pathophysiology and immunopathology of infectious and autoimmune diseases and with previous work in neuroscience and cancer. She is interested in developing physiological biomarkers for early detection of malaria, sepsis and antiphospholipid syndrome with particular interest in the clinical translation of novel targeted therapies.

Fatima is passionate about the dissemination of innovative academic and commercial research. She believes that these two sectors need better communication to drive translation and enable the permeation of top Early-to-Mid-Career researchers from academia into industry.


Dr Charlene Lobo – Public Officer and co-founder.

Charlene is currently a senior lecturer in the school of mathematical and physical sciences at UTS. She was previously employed as a senior scientist at FEI company (US) and was also one of the founding editors of Nature Materials, the leading international journal in materials science.

Since gaining her PhD in 2001, her nonlinear career path has taken her across the world, from Perth to Sydney via Cambridge UK, Boston MA and Portland, Oregon. Her expertise is in fabrication of nanostructured materials such as quantum dots for applications in optoelectronics and sensors. Her research webpage is here.

Charlene has a strong interest in communication of science to the general public, as well as in ensuring that the scientific community is both representative of the wider community and represents the public interest.


Dr Mana Liao – Treasurer.


Mana is currently a postdoctoral fellow at the Garvan Institute of Medical Research. She specialises in the identification and validation of novel drug targets for diabetes and obesity using proteomics technologies. During the course of her PhD, Mana has gained interest in biotechnology business development, which leads to her recent internships as the business analyst with Bio-Link Australia Pty Ltd, a life science commercialisation company and as the intellectual property and commercialisation analyst with Research and Innovation Office at UTS.

Mana believes more cross talks are needed between academia and industry to promote efficiency in translating innovations to make a measurable impact in society. Through NSW EMCR Network, she aspires to provide a platform to facilitate the industry-academic communication.


Dr Xavier Vidal – Committee Member.

Xavier is a research fellow in nanophotonics the department of Physics and Astronomy at Macquarie University. His expertise range different topics in optics from nonlinear optics to complex systems with special emphasis on light-matter interactions at the nanoscale and also chiral systems.

Xavier believes that a more natural and easy bridge between the academia and the private sector should exist. He is particularly interested in translating innovation and science created in the academia to society. He joined EMCR NSW Network with the aim to reveal opportunities of innovation between the academy research and technology companies.

For more information, please visit Xavier’s webpage.


Dr Adrian Murdock – Committee Member.

Adrian is an OCE Postdoctoral Research Fellow at CSIRO. His research focuses on the synthesis of novel nanomaterials such as graphene, atomic-scale electron microscopy of these structures, and then applications ranging from future energy storage devices to water membranes.

Adrian has broad interests around Australian scientific innovation and impact, science policy, and STEM education. He has over 10 years’ experience in teaching, tutoring, and science communication.

Further details can be found: http://people.csiro.au/M/A/Adrian-Murdock.


Former members.

Leave a Reply

Your email address will not be published. Required fields are marked *